FACULTY
Sanford M. Silverman, MD
Clinic Associate Professor
Affiliated Anesthesiology
Nova Southeastern University College of Allopathic Medicine
Davie, Florida
PROGRAM OVERVIEW
This three-part podcast series is designed to provide clinicians with practical, evidence-based strategies for assessing and managing pain, while balancing the risks and benefits of opioid therapy. Each episode focuses on a different aspect of pain management and opioid stewardship, offering actionable insights that can be applied in everyday practice.
TARGET AUDIENCE
Consistent with the goals of the FDA REMS blueprint, this REMS-compliant continuing education program is designed to meet the educational needs of a broad range of health care professionals, nationally, including medication prescribers and care team members; physicians (including primary care, internal medicine, emergency medicine, surgery, pain medicine, addiction medicine), advanced practice nurses (eg, APRN, CNS, NP, DNP, CRNA, CNMW, other), physician assistants, dentists, podiatrists, nurses, pharmacists, optometrists, and psychologists.
LEARNING OBJECTIVES
Upon completion of this program, attendees should be able to:
- Articulate the foundational elements of pain management, distinguishing between definitions, classifications, and mechanisms of pain
- Conduct comprehensive pain assessments that evaluate pain severity and identify patient-specific risk factors for nonmedical opioid use and opioid use disorder
- Apply effective strategies for managing acute and chronic pain that prioritize the use of nonpharmacologic and non-opioid pharmacologic modalities
- Develop guideline-driven strategies for initiating, titrating, and discontinuing opioid analgesics, while emphasizing individualized treatment plans, secure storage protocols, and counseling approaches for patients and caregivers concerning naloxone use during opioid overdose
- Recognize clinical indicators for specialist referral and facilitate timely consultations with pain management and addiction medicine
- Outline the core principles of addiction medicine and apply evidence-based strategies for recognizing and managing opioid use disorder
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 knowledge-based CPE contact hours.
Note to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designed for 1.5 AAPA Category 1 CME credits. Approval is valid until 10/15/2026. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Sanford M. Silverman, MD | No relationships to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Brianna Hefele, PA-C, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Scott, Medical Director for Med Learning Group, has nothing to disclose.
- Amanda Jenkins, Program Manager for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, dietary, physical, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: October 15, 2025
EXPIRATION DATE: October 15, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
